Great Lakes Advisors LLC reduced Amgen stock position by 18.5% in Q4, selling 75,351 shares.
Great Lakes Advisors LLC reduced its Amgen (NASDAQ: AMGN) stock position by 18.5% in Q4, owning 331,137 shares after selling 75,351 shares. Amgen reported $3.96 EPS for Q4, beating consensus estimate by $0.20, and had revenue of $7.45bn, up 22% YoY. Several institutional investors made changes to their Amgen positions. The consensus rating from analysts is 'Moderate Buy' with a target price of $305.65.
May 18, 2024
3 Articles